Human services officials say more treatment options are needed to place children, but lawmakers are concerned lighter regulations will create more problems.
As residents of Pennsylvania and New Jersey began 2025, several new laws took effect, including expanded access to health care and pay raises for top government officials. In its most recent ...
LUMRYZ, is an extended-release sodium oxybate medication approved by the FDA on May 1, 2023, as the first and only once-at-bedtime treatment for cataplexy or excessive daytime sleepiness (EDS) in ...